Skip to main content

Find Clinical Trials

Home
Conditions
High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

Clinical trial condition

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

Explore clinical trials studying High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) trial results

Not Yet Recruiting

Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)

NCT06099990

Conditions: High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC), Neoplasm Metastasis, Neoplasms, +3 more
Locations: Not specified

View Trial Details